Huali Wu

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Interpreting population pharmacokinetic‐pharmacodynamic analyses – a clinical viewpoint 2010 Stephen B. Duffull
Daniel F. B. Wright
Helen Winter
1
+ Effect of Obesity on the Pharmacokinetics of Drugs in Humans 2010 Michael J. Hanley
Darrell R. Abernethy
David J. Greenblatt
1
+ Assessing the Impact of Protocol Design Changes on Clinical Trial Performance 2008 Kenneth Getz
Julia Wenger
R. Campo
Edward S Seguine
Kenneth I. Kaitin
1
+ PDF Chat Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods 2013 DR Mould
Richard N. Upton
1
+ Development of a Physiology-Based Whole-Body Population Model for Assessing the Influence of Individual Variability on the Pharmacokinetics of Drugs 2007 Stefan Willmann
Karsten Höhn
Andrea N. Edginton
Michael Sevestre
Juri Solodenko
Wolfgang Weiß
Jörg Lippert
Walter Schmitt
1
+ Evaluation of different tests based on observations for external model evaluation of population analyses 2009 Karl Brendel
Emmanuelle Comets
CĂ©line M. Laffont
France Mentré
1
+ Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification 2015 Jennifer E. Sager
Jingjing Yu
Isabelle Ragueneau‐Majlessi
Nina Isoherranen
1
+ Safe and Effective Variability—A Criterion for Dose Individualization 2012 Nicholas H. G. Holford
Thierry Buclin
1
+ PDF Chat Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics 2016 Thi Huyen Tram Nguyen
Samer Mouksassi
Nicholas H. G. Holford
Nidal Al‐Huniti
Immanuel Freedman
Andrew C. Hooker
Johina M. John
Mats O. Karlsson
Diane R. Mould
Juan José Pérez Ruixo
1
+ Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamics in Clinical Pharmacology 2018 Daniel F. B. Wright
Chihiro Hasegawa
Hesham S. Al‐Sallami
1